EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

CHST4 associates with high-abundance immune infiltration in hormone receptor–positive breast cancer

Yansong Liu, Anbang Hu, Suborna S Shakila, Weilun Cheng, Ting Wang, Jiarui Zhang, Tianshui Yu, Yunqiang Duan, Jianyuan Feng, Yu Ding, Hanyu Zhang, Yanling Li und 7 weitere

Journal of Leukocyte Biology · 2024

DOI: 10.1093/jleuko/qiae190 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Leukocyte Biology, 2024. Verfasst von Yansong Liu und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, The Second Affiliated Hospital of Harbin Medical University, Harbin 150086, China. Hauptthemen laut MEDLINE: Breast Neoplasms, Sulfotransferases, Lymphocytes, Tumor-Infiltrating. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hormone receptor–positive breast cancer (HR+ BRCA) with high-risk factors such as lymph node metastasis has a relatively poor prognosis. However, the biological basis of tumor cell migration is still poorly understood, especially as some of the metastatic events occur at an early stage. Here, we identified that CHST4 (carbohydrate sulfotransferase 4), which has an important role in lymphocyte homing, was abnormally downregulated in HR+ BRCA and associated with lymph node metastasis. By enrichment analysis and immune infiltration evaluation, we predicted the potential ability of CHST4 to enhance immune cell infiltration. Then, immunohistochemical staining further demonstrated the contribution of CHST4 to the infiltration abundance of CD8+ T cells and CD4+ T cells in HR+ BRCA. Immunohistochemical staining of MECA-79 further identified the correlation between CHST4 and sulfated peripheral node addressin. Finally, we demonstrated that CHST4 was connected to increased tumor-immune cell communication by analyzing single-cell sequencing data. In summary, our study provided novel insights into the regulation of HR+ BRCA immune infiltration by CHST4.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsSulfotransferasesLymphocytes, Tumor-InfiltratingHumansFemaleLymphatic MetastasisCD8-Positive T-LymphocytesCD4-Positive T-LymphocytesReceptors, EstrogenGene Expression Regulation, NeoplasticCell Line, TumorReceptors, Progesterone

Stichwörter der Autor:innen

CHST4hormone receptor-positive breast cancerimmune cell infiltrationmetastasis

Substanzen

SulfotransferasesReceptors, EstrogenReceptors, Progesterone

Autor:innen und Institutionen

  • Department of General Surgery, The Second Affiliated Hospital of Harbin Medical University, Harbin 150086, China.
  • Department of General Surgery, Daqing Oilfield General Hospital, Daqing 163316, China.

ORCID-Profile: Baoliang Guo

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Liu, Y., Hu, A., Shakila, S. S., Cheng, W., Wang, T., Zhang, J., Yu, T., Duan, Y., Feng, J., Ding, Y., Zhang, H., Li, Y., Li, M., Rong, Z., Shang, Y., Fang, Z., Liu, J., Kong, F., & Guo, B. (2024). CHST4 associates with high-abundance immune infiltration in hormone receptor–positive breast cancer. Journal of Leukocyte Biology. https://doi.org/10.1093/jleuko/qiae190

Vancouver

Liu Y, Hu A, Shakila SS, Cheng W, Wang T, Zhang J, et al. CHST4 associates with high-abundance immune infiltration in hormone receptor–positive breast cancer. Journal of Leukocyte Biology. 2024. doi:10.1093/jleuko/qiae190

BibTeX
@article{Liu2024,
  author = {Liu, Yansong and Hu, Anbang and Shakila, Suborna S and Cheng, Weilun and Wang, Ting and Zhang, Jiarui and Yu, Tianshui and Duan, Yunqiang and Feng, Jianyuan and Ding, Yu and Zhang, Hanyu and Li, Yanling and Li, Mingcui and Rong, Zhiyuan and Shang, Yuhang and Fang, Zhengbo and Liu, Jiangwei and Kong, Fanjing and Guo, Baoliang},
  title = {CHST4 associates with high-abundance immune infiltration in hormone receptor–positive breast cancer},
  journal = {Journal of Leukocyte Biology},
  year = {2024},
  doi = {10.1093/jleuko/qiae190}
}
Kostenlos starten →